Telomir Pharmaceuticals I... (TELO)
NASDAQ: TELO
· Real-Time Price · USD
1.27
0.09 (7.63%)
At close: Sep 04, 2025, 11:30 AM
Telomir Pharmaceuticals Common Stock Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
Net Income | -16.08M | -12.46M | -16.53M | -22.96M | -18.74M | -18.84M | -13.07M | -4.23M | -2.75M | -1.2M | -720.73K | -233.63K | -136.84 | -66.78 |
Depreciation & Amortization | n/a | n/a | 4.34M | 4.34M | 4.34M | 4.34M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 8.1M | 3.44M | 2.06M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 12.53K | 10.62K | -57.16K | -76.38K | -87.81K | 1.29M | 1.39M | 1.39M | 1.39M | n/a | n/a | n/a | n/a | n/a |
Other Non-Cash Items | 4.91M | 4.82M | 9.19M | 9.79M | 5.74M | 5.95M | 1.61M | 649.67K | -258.61K | -382.65K | -382.4K | -151.1K | 6.37 | 1.54 |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -97.66K | 204.34K | 211.3K | 133.78K | -1.04M | 343.29K | 113.84K | 322.15K | 1.52M | 129.61K | 382.41K | 151.1K | n/a | n/a |
Operating Cash Flow | -3.17M | -3.99M | -5.07M | -5.55M | -6.55M | -5.06M | -3.86M | -3.03M | -1.11M | -1.07M | -338.32K | -82.53K | -130.48 | -65.24 |
Capital Expenditures | 4.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | -31.44K | 101K | n/a | 965.38K | 2.66M | 3.01M | 3.12M | 2.05M | 567.91K | 80K | 80K | 80K | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 6.85M | 6.99M | 6.47M | -371.89K | -27.62K | -23.66K | 231.94K | 498.21K | 68.41K | -67.92K | 196.02K | 139.20 | 139.20 | 69.60 |
Financial Cash Flow | 2.04M | 1.12M | 6.34M | 6.38M | 8.42M | 8.34M | 3.86M | 3.02M | 1.11M | 1.07M | 331.02K | 80.14K | 139.20 | 69.60 |
Net Cash Flow | -1.13M | -2.87M | 1.26M | 832.19K | 1.87M | 3.27M | -188 | 2.45K | 12.23K | -594.33 | -982.33 | -2.4K | n/a | n/a |
Free Cash Flow | -3.17M | -3.99M | -5.07M | -5.55M | -6.55M | -5.06M | -3.86M | -3.03M | -1.11M | -1.07M | -338.32K | -82.53K | -130.48 | -65.24 |